Tci Gene Inc.(TW:6879)
NT$35.500.00 (0.00%)
TW:6879
Tci Gene Inc. financials statements
NT$35.50
At close:0.00 (0.00%)
Tci Gene Inc. (6879) Ratios
Tci Gene Inc. Ratios
TW:6879's free cash flow for Q2 2026 was NT$19.19M. For the 2026 fiscal year, TW:6879's free cash flow was increased by NT$0.00 and operating cash flow was NT$19.19M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.27 | 9.82 | 6.87 | 7.52 | 2.87 |
| Quick Ratio | 9.08 | 9.38 | 6.50 | 7.12 | 2.69 |
| Cash Ratio | 2.54 | 0.97 | 4.47 | 6.51 | 1.93 |
| Solvency Ratio | 0.53 | 0.69 | 0.18 | 0.71 | 0.77 |
| Operating Cash Flow Ratio | 1.53 | 0.56 | 0.11 | 0.77 | 0.70 |
| Short-Term Operating Cash Flow Coverage | 195.26 | 73.50 | 30.56 | 185.78 | 82.48 |
| Net Current Asset Value | NT$ 815.65M | NT$ 892.99M | NT$ 913.17M | NT$ 932.88M | NT$ 316.84M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.02 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.13 | 1.18 | 1.16 | 1.47 |
| Debt Service Coverage Ratio | 15.19 | 55.76 | 19.27 | 72.87 | 57.51 |
| Interest Coverage Ratio | 14.97 | 106.06 | 5.01 | 106.29 | 136.01 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.33 | 0.05 | 0.30 | 0.14 | 0.48 |
| Net Debt to EBITDA | -7.40 | -1.19 | -26.62 | -7.68 | -2.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.77% | 58.72% | 52.30% | 57.39% | 55.40% |
| EBIT Margin | 7.65% | 19.58% | 2.98% | 21.46% | 27.13% |
| EBITDA Margin | 12.03% | 23.55% | 7.76% | 28.57% | 35.96% |
| Operating Profit Margin | 7.65% | 15.11% | 1.78% | 21.36% | 26.28% |
| Pretax Profit Margin | 14.24% | 19.44% | 2.63% | 21.26% | 26.94% |
| Net Profit Margin | 14.83% | 16.20% | 3.50% | 17.01% | 21.39% |
| Continuous Operations Profit Margin | 14.28% | 16.26% | 5.08% | 17.53% | 21.32% |
| Net Income Per EBT | 104.09% | 83.35% | 133.03% | 80.04% | 79.40% |
| EBT Per EBIT | 186.19% | 128.68% | 147.98% | 99.52% | 102.53% |
| Return on Assets (ROA) | 4.01% | 5.12% | 1.00% | 6.20% | 16.50% |
| Return on Equity (ROE) | 4.56% | 5.78% | 1.18% | 7.18% | 24.32% |
| Return on Capital Employed (ROCE) | 2.29% | 5.26% | 0.59% | 8.88% | 29.05% |
| Return on Invested Capital (ROIC) | 2.28% | 4.40% | 0.58% | 7.30% | 22.51% |
| Return on Tangible Assets | 4.03% | 5.14% | 1.01% | 6.24% | 16.68% |
| Earnings Yield | 4.47% | 3.93% | 0.54% | 2.51% | 4.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.41 | 3.32 | 3.25 | 5.79 | 3.69 |
| Payables Turnover | 4.82 | 3.61 | 2.11 | 3.02 | 2.70 |
| Inventory Turnover | 6.45 | 3.27 | 2.75 | 3.17 | 6.17 |
| Fixed Asset Turnover | 22.47 | 31.94 | 15.24 | 16.64 | 10.36 |
| Asset Turnover | 0.27 | 0.32 | 0.29 | 0.36 | 0.77 |
| Working Capital Turnover Ratio | 0.32 | 0.38 | 0.36 | 0.68 | 1.81 |
| Cash Conversion Cycle | 48.35 | 120.47 | 72.09 | 57.33 | 23.12 |
| Days of Sales Outstanding | 67.51 | 110.08 | 112.16 | 63.09 | 98.95 |
| Days of Inventory Outstanding | 56.56 | 111.60 | 132.62 | 115.22 | 59.14 |
| Days of Payables Outstanding | 75.72 | 101.21 | 172.69 | 120.98 | 134.98 |
| Operating Cycle | 124.08 | 221.68 | 244.78 | 178.30 | 158.10 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.92 | 2.15 | 0.67 | 4.51 | 6.24 |
| Free Cash Flow Per Share | 5.91 | 2.05 | 0.55 | 3.88 | 5.01 |
| Dividend Paid and CapEx Coverage Ratio | 2.84 | 1.96 | 0.32 | 1.60 | 5.09 |
| Capital Expenditure Coverage Ratio | 362.90 | 21.38 | 5.64 | 7.22 | 5.09 |
| Operating Cash Flow Coverage Ratio | 21.32 | 73.50 | 2.63 | 44.62 | 14.41 |
| Operating Cash Flow to Sales Ratio | 0.55 | 0.16 | 0.05 | 0.26 | 0.28 |
| Free Cash Flow Yield | 16.64% | 3.79% | 0.68% | 3.30% | 5.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.20 | 25.57 | 185.23 | 39.83 | 20.56 |
| Price-to-Sales (P/S) Ratio | 3.31 | 4.13 | 6.46 | 6.79 | 4.40 |
| Price-to-Book (P/B) Ratio | 1.02 | 1.47 | 2.19 | 2.86 | 5.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.01 | 26.41 | 146.99 | 30.27 | 19.86 |
| Price-to-Operating Cash Flow Ratio | 5.99 | 25.17 | 120.92 | 26.07 | 15.95 |
| Price-to-Earnings Growth (PEG) Ratio | -0.83 | 0.07 | -2.18 | -1.02 | 0.14 |
| Enterprise Value Multiple | 20.15 | 16.33 | 56.74 | 16.07 | 10.19 |
| Enterprise Value | 663.15M | 1.34B | 1.47B | 1.95B | 1.58B |
| EV to EBITDA | 20.15 | 16.33 | 56.74 | 16.07 | 10.19 |
| EV to Sales | 2.42 | 3.85 | 4.40 | 4.59 | 3.66 |
| EV to Free Cash Flow | 4.39 | 24.61 | 100.05 | 20.48 | 16.54 |
| EV to Operating Cash Flow | 4.38 | 23.46 | 82.30 | 17.64 | 13.29 |
| Tangible Book Value Per Share | 35.59 | 37.54 | 37.94 | 41.40 | 20.14 |
| Shareholders’ Equity Per Share | 34.86 | 36.84 | 37.25 | 41.05 | 19.90 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.16 | -0.93 | 0.18 | 0.21 |
| Revenue Per Share | 10.71 | 13.14 | 12.61 | 17.32 | 22.62 |
| Net Income Per Share | 1.59 | 2.13 | 0.44 | 2.95 | 4.84 |
| Tax Burden | 1.04 | 0.83 | 1.33 | 0.80 | 0.79 |
| Interest Burden | 1.86 | 0.99 | 0.88 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.12 | 0.10 | 0.14 | 0.15 | 0.14 |
| SG&A to Revenue | 0.36 | 0.33 | 0.37 | 0.21 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Income Quality | 3.73 | 0.84 | 2.03 | 1.53 | 1.29 |
Currency in TWD
